Ducks are relatively resistant to disease, but they have been known to carry diseases that are infectious to other types of poultry. However, some of the common diseases in ducks include duck virus hepatitis, duck plague, pasteurellosis, and aflatoxicosis. As there is no treatment for many of these diseases, such as duck plague, duck hepatitis, and others, vaccinating the ducks is essential to prevent such diseases. Also, providing proper housing, management, ventilation, and nutrition to ducks can make them less susceptible to diseases.
The global duck medicine and vaccines market is estimated to be valued at US$ 1,777.0 million in 2021 and is expected to exhibit a CAGR of 7.7% during the forecast period (2021-2028).
Figure 1. Global Duck Medicine and Vaccines Market Share (%) in Terms of Value, by Type, 2021
Increasing demand of poultry industry that include ducks is expected to drive the market growth during the forecast period.
A major part of the poultry industry is constituted by ducks worldwide, which is expected to drive the market growth over the forecast period. For instance, according to an article published by ScienceDirect on September 2021, there were 33.51 million ducks as per the 20th livestock census against 23.53 million in the 19th livestock census in India which shows a change of 42.4%. This means that the demand for ducks and duck farming is increasing, mandating the need for proper surveillance and monitoring of diseases affecting ducks in order to control them.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2020 | Market Size in 2021: | US$ 1,777.0 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR: | 7.7% | 2028 Value Projection: | US$ 2,992.1 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Duck Medicine and Vaccines Market Share (%), by Application, 2021
Increasing prevalence of viral and bacterial diseases of ducks is expected to drive market growth during the forecast period.
The increasing prevalence of viral and bacterial infectious diseases in ducks is expected to drive market growth during the forecast period. For instance, according to an article published by ScienceDirect in September 2021, duck diseases were underreported between 2000 and 2007, but several reports on disease prevalence showed a gradual increase from 2008 to 2015.
Global Duck Medicine and Vaccines Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus pandemic has negatively impacted the development, production, and supply of medicines and the growth of the pharmaceutical businesses of various companies across the globe. The lockdown has resulted in the closure of industrial establishments, except for the manufacturing of essential commodities and there has been disruption in the supply chain of pharmaceuticals. Thus, the COVID-19 pandemic has affected the economy in three main ways: 1) by directly affecting the production and demand; 2) disrupting distribution channels; and 3) causing financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to the global lockdown, while many countries, such as Saudi Arabia, the UAE, Egypt, and others, are facing problems with regard to the transportation of drugs from one place to another. Due to all these reasons, the growth of global duck medicines and vaccines market was negatively hampered.
Global Duck Medicine and Vaccines Market: Restraint
The major factors that hinder growth of the global duck medicine and vaccines market include high treatment cost and limited access to the vaccines in emerging economies, such as India, Brazil, and others.
Key Players
Major players operating in the global duck medicine and vaccines market include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.
Market Dynamics
The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients